Lymphangioma secondary prevention: Difference between revisions
No edit summary |
Badria Munir (talk | contribs) No edit summary |
||
| (5 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
{{Lymphangioma}} | {{Lymphangioma}} | ||
__NOTOC__ | |||
{{Xyz}} | |||
{{CMG}}; {{AE}} {{Badria}} | |||
== | ==Overview== | ||
There are no established measures for the secondary prevention of [[lymphangioma]]. | |||
==Secondary Prevention== | |||
There are no established measures for the secondary prevention of [[lymphangioma]]. | |||
[[ | |||
==References== | |||
{{Reflist|2}} | |||
{{ | {{WH}} | ||
{{ | {{WS}} | ||
[[Category: (name of the system)]] | |||
Latest revision as of 21:16, 1 November 2018
|
Lymphangioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphangioma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Lymphangioma secondary prevention |
|
Risk calculators and risk factors for Lymphangioma secondary prevention |
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphangioma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Lymphangioma secondary prevention |
|
Risk calculators and risk factors for Lymphangioma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[2]
Overview
There are no established measures for the secondary prevention of lymphangioma.
Secondary Prevention
There are no established measures for the secondary prevention of lymphangioma.